BridgeMD
New treatment option for Shoulder Pain
Official title Dexmedetomidine as an Adjuvant to Bupivacaine in Ultrasound-guided Pericapsular Nerve Group Block( PENG)
ClinicalTrials.gov ID: NCT07626346
What this study is testing
- What it's testing
- Patients are greatly concerned about pain that occurs shortly after shoulder surgeries. Most patients experience significant pain after shoulder surgery, with almost half reporting severe pain immediately after.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Male or female patients aged 18-65 years
- Patients Undergoing laparoscopic shoulder surgeries (shoulder arthroplasties and shoulder endoscopic surgeries )
- American Society of Anesthesiologists (ASA) physical status I-II
You likely can't join if
- Patient refusal.
- hypersensitivity or contraindication to dexmedetomidine
- History of allergy or intolerance to study medications
- Chronic opioid use (\>3 months)
- Pregnancy or breastfeeding
- Severe renal or hepatic impairment
See the full eligibility criteria
- Male or female patients aged 18-65 years
- Patients Undergoing laparoscopic shoulder surgeries (shoulder arthroplasties and shoulder endoscopic surgeries )
- American Society of Anesthesiologists (ASA) physical status I-II
- Patient refusal.
- hypersensitivity or contraindication to dexmedetomidine
- History of allergy or intolerance to study medications
- Chronic opioid use (\>3 months)
- Pregnancy or breastfeeding
- Severe renal or hepatic impairment
- Patient's with coagulopathy disorders
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.